Referencias►
1.
Shils ME, Olson JA, Shike M, eds.
Modern Nutrition in Health and Disease.
9th ed. Baltimore: Williams & Wilkins; 1999: 1772.
2.
Shils ME, Olson JA, Shike M, eds.
Modern Nutrition in Health and Disease.
9th ed. Baltimore: Williams & Wilkins; 1999: 210, 860, 1422, 1424.
3. Nelson M, Ash R, Mulvhill C, et al. Iron status, diet and cognitive function in British adolescent girls. Poster presented at: The Nutrition Society's Nutrition 2000 - Research Themes for the New Millenium; June 26 - 30; University College, Cork, Ireland.
4.
Kara M, Hasinoff BB, McKay DW, et al. Clinical and chemical interactions between iron preparations and ciprofloxacin.
Br J Clin Pharmacol.
1991;31:257 - 261.
5.
Polk RE, Healy DP, Sahai J, et al. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers.
Antimicrob Agents Chemother.
1989;33:1841 - 1844.
6.
Campbell NR, Kara M, Hasinoff BB, et al. Norfloxacin interaction with antacids and minerals.
Br J Clin Pharmacol.
1992;33:115 - 116.
7.
Lehto P, Kivisto KT. Different effects of products containing metal ions on the absorption of lomefloxacin.
Clin Pharmacol Ther.
1994;56:477 - 482.
8.
Lehto P, Kivisto KT, and Neuvonen PJ. The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin.
Br J Clin Pharmacol.
1994;37:82 - 85.
9.
Neuvonen PJ. Interactions with the absorption of tetracyclines.
Drugs.
1976;11:45 - 54.
10.
Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions.
Br J Clin Pharmacol.
1991;31:251 - 255.
11.
Heinrich HC, Oppitz KH, Gabbe EE. Inhibition of iron absorption in man by tetracycline [in German].
Klin Wochenschr.
1974;52:493 - 498.
12.
Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions.
Br J Clin Pharmacol.
1991;31:251 - 255.
13.
Campbell N, Paddock V, Sundaram R. Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and ferrous gluconate.
Clin Pharmacol Ther.
1988;43:381 - 386.
14.
Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions.
Br J Clin Pharmacol.
1991;31:251 - 255.
15.
Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions.
Br J Clin Pharmacol.
1991;31:251 - 255.
16.
Osman MA, Patel RB, Schuna A, et al. Reduction in oral penicillamine absorption by food, antacid, and ferrous sulfate.
Clin Pharmacol Ther.
1983;33:465 - 470.
17.
Campbell NR, Hasinoff BB, Stalts H, et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism.
Ann Intern Med.
1992;117:1010 - 1013.
18.
Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions.
Br J Clin Pharmacol.
1991;31:251 - 255.
19.
Hallberg L. Does calcium interfere with iron absorption?
Am J Clin Nutr.
1998;68:3 - 4.
20.
Cook JD, Dassenko SA, Whittaker P. Calcium supplementation: effect on iron absorption.
Am J Clin Nutr.
199153:106 - 111.
21.
Dawson-Hughes B, Seligson FH, Hughes VA. Effects of calcium carbonate and hydroxyapatite on zinc and iron retention in postmenopausal women.
Am J Clin Nutr.
1986;44:83 - 88.
22.
Sokoll LJ, Dawson-Hughes B. Calcium supplementation and plasma ferritin concentrations in premenopausal women.
Am J Clin Nutr.
1992;56:1045 - 1048.
23.
Hallberg L, Rossander L, Skanberg AB. Phytates and the inhibitory effects of bran on iron absorption in man.
Am J Clin Nutr. 1987;45:988 - 996.
24.
Sandstrom B, Davidsson L, Cederblad A, et al. Oral iron, dietary ligands and zinc absorption.
J Nutr.
1985;115:411 - 414.
25.
Haschke F, Ziegler EE, Edwards BB, et al. Effect of iron fortification of infant formula on trace mineral absorption.
J Pediatr Gastroenterol Nutr.
1986;5:768 - 773.
26.
Freeland-Graves JH. Manganese: an essential nutrient for humans.
Nutr Today. 1988;23:13 - 19.
27.
Champagne ET. Low gastric hydrochloric acid secretion and mineral bioavailability.
Adv Exp Med Biol.
1989;249:173 - 184.
28.
Hinton PS, Giordano C, Brownlie T, et al. Iron supplementation improves endurance after training in iron-depleted, nonanemic women.
J Appl Physiol.
2000;88:1103 - 1111.
29. Nelson M, Ash R, Mulvhill C, et al. Iron status, diet and cognitive function in British adolescent girls. Poster presented at: The Nutrition Society's Nutrition 2000 - Research Themes for the New Millennium; June 26 - 30; University College, Cork, Ireland.
30.
O'Keeffe ST. Restless legs syndrome. A review.
Arch Intern Med.
1996;156:243 - 248.
31.
Sun ER, Chen CA, Ho G, et al. Iron and the restless legs syndrome.
Sleep.
1998;21:371 - 377.
32.
O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly
. Age Ageing.
1994;23:200 - 203.
33.
Davis BJ, Rajput A, Rajput ML, et al. A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome
. Eur Neurol.
2000;43:70 - 75.
34.
Castaldo A, Tarallo L, Palomba E, et al. Iron deficiency and intestinal malabsorption in HIV disease.
J Pediatr Gastroenterol Nutr. 1996;22:359 - 363.
35.
Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men.
J Acquir Immune Defic Syndr. 1993;6:949 - 958.
36.
Hinton PS, Giordano C, Brownlie T, et al. Iron supplementation improves endurance after training in iron-depleted, nonanemic women.
J Appl Physiol.
2000;88:1103 - 1111.
37.
Friedmann B, Weller E, Mairbaurl H, et al. Effects of iron repletion on blood volume and performance capacity in young athletes.
Med Sci Sports Exerc.
2001;33:741 - 746.
38.
Taymor ML, Sturgis SH, Yahia C. The etiological role of chronic iron deficiency in production of menorrhagia.
JAMA. 1964;187:323 - 327.
39.
Sempos CT, Looker AC, Gillum RE, et al. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study.
Ann Epidemiol. 2000;10:441 - 448.
40.
Davolos A, Castillo J, Marrugat J, et al. Body iron stores and early neurologic deterioration in acute cerebral infarction.
Neurology.
2000;54:1568 - 1574.
41.
Lao TT, Tam K, Chan LY. Third trimester iron status and pregnancy outcome in non-anaemic women; pregnancy unfavourably affected by maternal iron excess.
Hum Reprod.
2000;15:1843 - 1848.
42.
Maskos Z, Koppenol WH. Oxyradicals and multivitamin tablets.
Free Radic Biol Med.
1991;11:609 - 610.
43.
Conrad ME, Schade SG. Ascorbic acid chelates in iron absorption: a role for hydrochloric acid and bile.
Gastroenterology.
1968;55:35 - 45.
44.
Brise H, Hallberg L. Effect of ascorbic acid on iron absorption.
Acta Med Scand.
1962;171(suppl 376):51.
45.
Lynch SR, Cook JD. Interaction of vitamin C and iron.
Ann N Y Acad Sci.
1980;355:32 - 44.
46.
Hunt JR, Gallagher SK, Johnson LK. Effect of ascorbic acid on apparent iron absorption by women with low iron stores.
Am J Clin Nutr.
1994;59:1381 - 1385.
47.
Diplock AT. Safety of antioxidant vitamins and beta-carotene.
Am J Clin Nutr.
1995;62(suppl 6):1510S - 1516S.
48.
Hoffman KE, Yanelli K, Bridges KR. Ascorbic acid and iron metabolism: alterations in lysosomal function.
Am J Clin Nutr.
1991;54(suppl 6):1188S - 1192S.
49.
Siegenberg D, Baynes RD, Bothwell TH, et al. Ascorbic acid prevents the dose-dependent inhibitory effects of polyphenols and phytates on nonheme-iron absorption.
Am J Clin Nutr.
1991;53:537 - 541.
50.
Lee SC, Park SW, Kim DK, et al. Iron supplementation inhibits cough associated with ACE inhibitors.
Hypertension.
2001;38:166 - 170.
51.
Brutsaert TD, Hernandez-Cordero S, Rivera J, et al. Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women.
Am J Clin Nutr. 2003;77:441 - 448.
52.
Rowland TW, Deisroth MB, Green GM, Kelleher JF. The effect of iron therapy on the exercise capacity of nonanemic iron-deficient adolescent runners.
Am J Dis Child. 1988;142:165 - 169.
53.
Celsing F, Blomstrand E, Werner B, et al. Effects of iron deficiency on endurance and muscle enzyme activity in man.
Med Sci Sports Exerc. 1986;18:156 - 161.
54.
Klingshirn LA, Pate RR, Bourque SP, et al. Effect of iron supplementation on endurance capacity in iron-depleted female runners.
Med Sci Sports Exerc. 1992;24:819 - 824.
55.
LaManca JJ, Haymes EM. Effects of iron repletion on VO2max, endurance, and blood lactate in women.
Med Sci Sports Exerc. 1993;25:1386 - 1392.
56.
Verdon F, Burnand B, Fallab-Stubi CL, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial.
BMJ. 2003;326:1124.
57.
Dewey KG, Domellof M, Cohen RJ, et al. Iron supplementation affects growth and morbidity of breast-fed infants: results of a randomized trial in sweden and honduras.
J Nutr. 2002;132:3249 - 3255.
